Healthcare company Surgery Partners (NASDAQ:SGRY) in Q2 CY2025, with sales up 8.4% year on year to $826.2 million. The ...

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation ...

Explore Surgery Partners' Q2 2025 performance with $826M revenue & 9% EBITDA growth. Learn about M&A strategy, leadership changes, & market outlook.

Brentwood, Tenn.-based Surgery Partners is doubling down on independence following the decision not to proceed with Bain Capital’s proposed acquisition, according to the company’s second quarter ...

Surgery Partners met analysts’ revenue expectations last quarter, reporting revenues of $770.4 million, up 14.3% year on year. It was a slower quarter for the company, with a significant miss of ...

Surgery Partners is up 4.9% since the beginning of the year, but at $22.34 per share, it is still trading 33.7% below its 52-week high of $33.69 from August 2024. Investors who bought $1,000 worth ...

Surgery Partners outlines 2025 guidance with $3.3B-$3.45B revenue target, driven by high acuity growth Mar. 03, 2025 1:34 PM ET Surgery Partners, Inc. (SGRY) Stock AI-Generated Earnings Calls Insights ...

Surgery Partners, Inc. reported financial results for the first quarter of 2025, highlighting an 8.2% increase in revenue to $776 million compared to the same quarter in 2024, along with a 5.2% ...

UnitedHealth Group has announced the appointment of Wayne DeVeydt, former CEO of ASC chain Surgery Partners, as its new chief financial officer, effective September 2. Here are three points to know: 1 ...

Analysts' ratings for Surgery Partners (NASDAQ:SGRY) over the last quarter vary from bullish to bearish, as provided by 7 analysts.In the table below, you'll find a summary of their recent ratings ...

Get the latest news on Surgery Partners stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on SGRY performance ...